Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SCGB3A1 encodes a small secreted protein that may function in the inhibition of cell growth. Additionally we are shipping SCGB3A1 Proteins (5) and SCGB3A1 Kits (2) and many more products for this protein.
Showing 10 out of 35 products:
Human Polyclonal SCGB3A1 Primary Antibody for ELISA - ABIN450068
Wu, Lothe, Ahlquist, Silins, Tropé, Micci, Nesland, Suo, Lind: DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. in Molecular cancer 2007
Tumor-adjacent tissues showed higher methylation status of RASSF1A (show RASSF1 Antibodies), HIN-1 (show OTUD4 Antibodies) and MGMT (show MGMT Antibodies) promoters.
SCGB3A1-183 T and SCGB3A1 IVS1-189 A alleles might have a protective effect against nasal polyposis.
aberrant HIN-1 (show OTUD4 Antibodies) promoter methylation could be an independent and important biomarker used in predicting the prognosis and progression of breast cancer
Methylation of HIN-1 (show OTUD4 Antibodies) promoter is a novel epigenetic biomarker associated with poor outcomes in OCCA patients.
Methylation of HIN-1 (show OTUD4 Antibodies), RASSF1A (show RASSF1 Antibodies), RIL (show PDLIM4 Antibodies) and CDH13 (show CDH13 Antibodies) in breast cancers was associated with clinical characteristics, but only RASSF1A (show RASSF1 Antibodies) methylation was associated with time to first recurrence and overall survival.
HIN1 (show OTUD4 Antibodies), was the most "dietary sensitive" genes, as methylation of their promoters was associated with intakes of at least two out of the eight dietary methyl factors examined.
analysis of AKT (show AKT1 Antibodies) signaling pathway activated by HIN-1 (show OTUD4 Antibodies) methylation in non-small cell lung cancer
Data show that SCGB3A1 was down-regulated in invasive compared with DCIS, whereas talin 2 (TLN2 (show TLN2 Antibodies)) and PTGS1 (show PTGS1 Antibodies) were up-regulated in invasive compared with DCIS.
Data suggest that high methylation of the HIN-1 (show OTUD4 Antibodies) promoter results in silenced HIN-1 (show OTUD4 Antibodies) expression in gastric cancer, and that 5-aza-2'-deoxycytidine reverses HIN-1 (show OTUD4 Antibodies) methylation and reduces viability of gastric cancer cells.
The methylation levels and frequencies of HIN1 (show OTUD4 Antibodies), RASSF1A (show RASSF1 Antibodies) and TWIST, and average MR were significantly lower in basal-like subtype compared to luminal or human epithelial growth factor receptor (show RYK Antibodies)-2 subtype.
Neonatal hyperoxia followed by RA recovery was associated with decreased lung CCSP and SCGB3A1 protein but not mRNA expression.
The differential expression of mRNA by both airway level and lung region was determined for uteroglobin-related protein 2.
Highest HIN-1 and UGRP-1 (show SCGB3A2 Antibodies) expression is detected in the lung, while lower level HIN-1 expression is also detected in the stomach, heart, small intestine, uterine and mammary glands
genomic structure and expression patterns of Ugrp2 and its alternative spliced form were characterized
EGF (show EGF Antibodies)-induced increase of Ugrp2 occurred at the transcriptional level that required the EGF receptor (show EGFR Antibodies) and the activation of the ERK-MAPK (show MAPK1 Antibodies) and phosphoinositide-3 kinase pathways
ubiquitous transcription factor NF-Y binds to and activates expression of the Scgb3a1 gene and tissue-specific expression of the gene is associated with CpG methylation of the promoter
The expression of SCGB3A1 and SCGB3A2 (show SCGB3A2 Antibodies) are bidirectionally regulated by oncostatin M (OSM (show OSM Antibodies)) when examined in a mouse transformed Clara cell line.
Expression of SCGB3A1 was down-regulated by IFN-gamma (show IFNG Antibodies) in a time- and dose-dependent manner in the murine transformed Clara Cells line.
This gene encodes a small secreted protein that may function in the inhibition of cell growth. Expression of the related gene in humans is downregulated via DNA methylation in breast cancers and other tumor types. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
, cytokine high in normal-1
, high in normal 1
, pneumo secretory protein 2
, secretoglobin family 3A member 1
, uteroglobin-related protein 2
, uteroglobin related protein 2